Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ruediger Ridder
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer
Clinical Cancer Research
Cancer Research
Oncology
Evaluating HPV-negative CIN2+ in the ATHENA Trial
International Journal of Cancer
Cancer Research
Oncology
Related publications
RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer
Clinical and Investigative Medicine
Medicine
Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients
Oncologist
Cancer Research
Medicine
Oncology
L1TD1 - A Prognostic Marker for Colon Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Expression of Aquaporin-1 Is a Poor Prognostic Factor for Stage II and III Colon Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer
Oncotarget
Oncology
Prognostic and Predictive Role of DNA Mismatch Repair Status in Stage II‐III Colorectal Cancer: A Systematic Review and Meta‐Analysis
Clinical Genetics
Genetics
P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer
Scientific Reports
Multidisciplinary
